Axsome Therapeutics records 29.06% CAGR over the past 5 years
AXSM Axsome Therapeutics Inc
$140.97 +5.23%
View chart & analysis → - 1Axsome Therapeutics recorded a compound annual growth rate of 29.06% over the past 5 years.
- 2Based on Axsome Therapeutics' current market capitalization of $7.5 billion, a $5,000 investment could potentially reach an estimated value of $49,670 in 9 years.
- 3While the outlook is attractive, it is highly unlikely that the company will maintain a 29.06% CAGR and become a $74.5 billion company.
So what's the key point?
Axsome Therapeutics has grown by an average of 29.06% every year for the past 5 years. While it is difficult for the company to keep growing to become a very large scale entity, there is investment value.
Source The Motley Fool · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.